The Full ASGCT 27th Annual Meeting Abstracts Collection is NOW LIVE! Click here to read the full collection.
Laura McWright, Deputy Director of the Seamless Care Models Group at the Centers for Medicaid and Medicare Innovation (CMMI), will discuss CMMI’s Cell & Gene Therapy Access Model at the Policy Summit. Register today to be part of this and more discussions with top CGT decision makers, Sept. 18-19 (virtually + in-person)!
At this year's Policy Summit, Centers for Medicaid and Medicare Innovation (CMMI) will cover new demonstration models for CGT in a fireside chat. ASGCT is excited to announce that Laura McWright, Deputy Director of the Seamless Care Models Group at CMMI, will be joining the event on the morning of Monday, Sept. 18.
The discussion will focus on the recent Cell and Gene Therapy Access Model from CMMI and other federal policy efforts on payment policy, with audience Q&A to round out the session. Join the discussion to hear more about CMS’ role in negotiating outcomes-based arrangements and how the agency is thinking about access to innovative therapies.
ASGCT's Policy Summit connects you with policy and industry leaders in the field where you'll learn from a variety of stakeholder perspectives and how they inform regulatory, legislative, and payment policies that impact gene and cell therapy development. Join us virtually or in person!
In-person registration will be extremely limited - so register today to secure your spot in Washington, D.C.!
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico